bezafibrate has been researched along with Kidney Diseases in 11 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 2 (18.18) | 18.7374 |
| 1990's | 2 (18.18) | 18.2507 |
| 2000's | 6 (54.55) | 29.6817 |
| 2010's | 1 (9.09) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Chen, Y | 1 |
| Furuyama, M; Hashimoto, T; Hayasaka, K; Matsunaga, A; Ogino, D; Toyoda, K | 1 |
| Arai, T; Himeno, S; Kanayama, Y; Kiriyama, K; Manabe, N; Matsuzaki, T; Matsuzawa, Y; Yamane, M; Yamashita, S | 1 |
| Fujita, T; Maeda, R; Negishi, K; Noiri, E; Portilla, D; Sugaya, T | 1 |
| Abshagen, U; Kaufmann, B; Kösters, W; Lang, PD | 1 |
| Jespersen, B; Tvedegaard, E | 1 |
| Abramowicz, D; Antoine, M; Broeders, N; Knoop, C; Tielemans, C | 1 |
| Bargman, JM; Lipscombe, J | 1 |
| Kamaliah, MD; Sanjay, LD | 1 |
| Frishman, WH; Kahn, S; Zimetbaum, P | 1 |
| Daher, E; Dakak, N; Khoury, K; Yeshurun, D | 1 |
2 review(s) available for bezafibrate and Kidney Diseases
| Article | Year |
|---|---|
Lipoprotein glomerulopathy in China.
Topics: Apolipoprotein E2; Apolipoproteins E; Asian People; Bezafibrate; China; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Kidney Diseases; Kidney Glomerulus; Proteinuria | 2014 |
Effects of gemfibrozil and other fibric acid derivatives on blood lipids and lipoproteins.
Topics: Bezafibrate; Cholesterol, HDL; Clofibric Acid; Diabetes Mellitus, Type 2; Fenofibrate; Fibric Acids; Gemfibrozil; Humans; Hypercholesterolemia; Hypertriglyceridemia; Hypolipidemic Agents; Kidney Diseases; Lipoproteins, VLDL; Metabolic Clearance Rate; Triglycerides | 1991 |
9 other study(ies) available for bezafibrate and Kidney Diseases
| Article | Year |
|---|---|
Improvement of nephrotic syndrome by intensive lipid-lowering therapy in a patient with lipoprotein glomerulopathy.
Topics: Adolescent; Angiotensin II Type 1 Receptor Blockers; Angiotensin-Converting Enzyme Inhibitors; Apolipoproteins E; Bezafibrate; Child; Child, Preschool; Enalapril; Female; Hematuria; Humans; Hypolipidemic Agents; Kidney Diseases; Kidney Failure, Chronic; Kidney Glomerulus; Nephrotic Syndrome; Probucol; Tetrazoles; Valine; Valsartan | 2009 |
Disappearance of intraglomerular lipoprotein thrombi and marked improvement of nephrotic syndrome by bezafibrate treatment in a patient with lipoprotein glomerulopathy.
Topics: Adult; Apolipoprotein E2; Apolipoproteins E; Bezafibrate; Cholesterol, HDL; Female; High-Density Lipoproteins, Pre-beta; Humans; Hypolipidemic Agents; Kidney Diseases; Kidney Glomerulus; Lipoproteins; Lipoproteins, HDL; Nephrotic Syndrome; Thrombosis | 2003 |
Renal L-type fatty acid-binding protein mediates the bezafibrate reduction of cisplatin-induced acute kidney injury.
Topics: Animals; Apoptosis; Bezafibrate; Cisplatin; Cytoprotection; Fatty Acid-Binding Proteins; Kidney; Kidney Diseases; Lipid Peroxidation; Mice; Mice, Transgenic; Necrosis; PPAR alpha; Reverse Transcriptase Polymerase Chain Reaction; RNA, Messenger | 2008 |
Pharmacokinetics of bezafibrate after single and multiple doses in the presence of renal failure.
Topics: Adult; Bezafibrate; Clofibrate; Clofibric Acid; Drug Administration Schedule; Female; Humans; Kidney Diseases; Kinetics; Male; Middle Aged | 1980 |
Bezafibrate induced reduction of renal function in a renal transplant recipient.
Topics: Bezafibrate; Humans; Hypercholesterolemia; Kidney Diseases; Kidney Transplantation; Male; Middle Aged | 1995 |
Fibrate-induced increase in blood urea and creatinine: is gemfibrozil the only innocuous agent?
Topics: Bezafibrate; Clofibric Acid; Creatinine; Fenofibrate; Fibric Acids; Gemfibrozil; Humans; Hypolipidemic Agents; Kidney Diseases; Kidney Transplantation; Postoperative Period; Retrospective Studies; Urea | 2000 |
Fibrate-induced increase in blood urea and creatinine.
Topics: Bezafibrate; Blood Urea Nitrogen; Clofibric Acid; Creatinine; Fenofibrate; Fibric Acids; Humans; Hyperlipidemias; Hypolipidemic Agents; Kidney Diseases | 2001 |
Rhabdomyolysis and acute renal failure following a switchover of therapy between two fibric acid derivatives.
Topics: Acute Kidney Injury; Aged; Bezafibrate; Coronary Disease; Gemfibrozil; Humans; Hyperlipidemias; Hypolipidemic Agents; Kidney Diseases; Male; Rhabdomyolysis | 2001 |
[Acute severe myositis due to bezafibrate treatment].
Topics: Acute Disease; Bezafibrate; Female; Follow-Up Studies; Humans; Hyperlipoproteinemia Type II; Kidney Diseases; Middle Aged; Myositis | 1989 |